141419-94-5

Basic information

• Product Name: Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate
• Synonyms: Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate;ethyl tetrahydro-4-oxo-2H-pyran-3-carboxylate
• CAS NO: 141419-94-5
• Molecular Formula: C8H12O4
• Molecular Weight: 172.17848
• Mol File: 141419-94-5.mol

Chemical Properties

• Boiling Point: 253.2±30.0 °C(Predicted)
• Appearance: /
• Density: 1.162±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 10?+-.0.20(Predicted)
• CAS DataBase Reference: Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate(141419-94-5)
• EPA Substance Registry System: Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate(141419-94-5)

Safety Data

• Hazardous Substances Data: 141419-94-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate is used as an intermediate in the synthesis of various pharmaceuticals for its ability to facilitate the production of complex organic molecules, contributing to the development of new drugs and medications.
Used as a Flavoring Agent in the Food Industry:
In the food industry, ethyl levulinic acid is used as a flavoring agent due to its fruity odor, enhancing the taste and aroma of various food products, thereby improving consumer appeal.
Used in Chemical Reactions as a Building Block:
Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate serves as a building block in various chemical reactions, enabling the creation of a diverse array of chemical compounds for different applications across multiple industries. Its reactivity and stability make it a valuable component in chemical synthesis processes.

Upstream product

• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 623-49-4 ethyl cyanoformate 
• 5961-83-1 3-(2-carboxyethoxy)propionic acid 
• 17615-27-9 diethyl-4-oxa-heptanedioate 
• 62957-60-2 2-ethoxyacetonitrile 
• 105-58-8 Diethyl carbonate 
• 541-41-3 chloroformic acid ethyl ester 

Downstream Products

• 19178-21-3 2-methyl-5,6,7,8-tetrahydronquinazolin-4(3H)-one 

Relevant articles and documents

Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors

The canonical WNT pathway plays an important role in cancer pathogenesis. Inhibition of poly(ADP-ribose) polymerase catalytic activity of the tankyrases (TNKS/TNKS2) has been reported to reduce the Wnt/β-catenin signal by preventing poly ADP-ribosylation-

TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS

The present invention provides compounds of Formula (A): (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent, and methods of using the compositions and combinations to treat conditions including cancers.

RHO KINASE INHIBITORS

The invention provides novel inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or ROCK2. The present invention includes pharmaceutical compositions comprising the compounds of the invention and a pharmaceutically acceptable carrier and/or diluents. The present invention includes compositions comprising a substantially pure compound of the invention and a pharmaceutically acceptable salt, steroisomer, or hydrate thereof: and a pharmaceutically acceptable excipient and/or diluents.

Dihydropyridazine derivatives with cyclopenta-, benzo-, furo-, thiopyrano-and pyrido-annulation

Regioisomeric [c]annulated pyridazines were prepared from arylhydrazines and carbocyclic or heterocyclic β-oxo esters with an α-phenacetyl moiety. With AcOH/EtOH, the hydrazones were preferentially formed at the endocyclic ketone, which are further cycliz

IMIDAZOPYRIDIN-2-ONE DERIVATIVES

A compound represented by formula (I) having mTOR inhibitory activity or a pharmacologically acceptable salt thereof.